NCT01875224View on ClinicalTrials.gov

Comparison of NODAT in Kidney Transplant Patients Receiving Belatacept Versus Standard Immunosuppression

PHASE4UnknownINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
New Onset Diabetes After TransplantKidney Transplantation
Interventions
DRUG

Belatacept

DRUG

Tacrolimus

Standard administration of tacrolimus

Trial Locations (1)

85724

University of Arizona, Tucson

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

University of Arizona

OTHER